7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,917.50

+34.99

+0.05%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

HKSE - Delayed Quote HKD

AIM Vaccine Co., Ltd. (6660.HK)

1.560 +0.065 (+4.35%)

At close: November 6 at 2:51:22 PM GMT+8

AIM Vaccine's 20-Valent Pneumococcal Conjugate Vaccine Receives Clinical Approval, Upgraded Iterative Major Product Expected to Seize Domestic Opportunities

PR Newswire 9mo ago

6660.HK
+4.35%
World's First Serum-Free Iterative Rabies Vaccine from AIM Successfully Passes On-Site Registration Inspections and Is Imminent for Launch

PR Newswire 8mo ago

6660.HK
+4.35%
Global Penny Stocks To Watch In January 2026

Simply Wall St. 9mo ago

IGL.AX

6660.HK
+4.35%
FSG.L

Mobilize your Website

View Site in Mobile | Classic

Share by: